Clinical Practice Connections™: New York Advanced Practice Collaborative

Released On
November 15, 2018

Expires On
November 15, 2019

Media Type

Completion Time
75 minutes

Allergy & Immunology, Cardiology, Dermatology, Endocrinology, Nephrology, Integrative Medicine, Primary Care

Major Chronic Illnesses

Scroll to the Bottom of this Information to Begin this Course

This activity is jointly provided by Global Education Group and Physicians’ Education Resource®, LLC.


Supported by an educational grant from Amgen, Biogen, Novo Nordisk, and Sunovion Pharmaceuticals, Inc.


Credit Available

  • Physicians — maximum of 1.25 AMA PRA Category 1 Credit(s)
  • Nurses — 1.25 contact hour(s) which includes 0.00 hour(s) of pharmacology
  • Physician Assistants — maximum of 1.25 AMA PRA Category 1 Credit(s)

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This curriculum is directed toward nurse practitioners and physician assistants practicing in the primary care setting. Physicians and other healthcare professionals interested in the treatment of patients in the primary care setting may also participate.

Program Overview

Community Practice Connections™: 1st Annual New York Advanced Practice Collaborative features a summary of guideline updates, clinical expertise, and new or emerging treatments for major chronic illnesses encountered daily in family practice medicine.

This activity will provide cutting-edge updates on 5 clinically relevant topic areas through video commentaries from leading faculty. Early diagnosis of all diseases is critical, but will be especially highlighted in Alzheimer’s disease to not only treat early and slow progression, but also improve quality of life for patients and caregivers. Reasons that ADHD in adults is frequently undiagnosed will be explored along with strategies for multi-modal, team-based care. Binge eating disorder is the most common eating disorder and requires specific and sensitive strategies for detection that will be shared along with nonpharmacologic and pharmacologic approaches to treatment. Similarly, the multiple tactics needed to incorporate lifestyle changes alongside pharmacologic treatment in patients with obesity will be shared along with insights on the impact of obesity on other diseases and conditions. New CGRP inhibition therapies for migraine will be described that can potentially address the adherence and patient satisfaction issues that practitioners frequently encounter.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the collaborative role of all providers on the healthcare team
  • Discuss evidence-based guidelines and recent clinical study results that affect clinical decision-making
  • Implement the latest diagnostic and treatment strategies for common conditions encountered in the primary care setting
  • Develop methods to enhance the relationship between provider and patient to improve health outcomes


Lawrence Herman, MPA, PA-C, DFAAPA

Adjunct Professor
School of Medicine
Associate Program Director
Physician Assistant Studies
University of Texas Medical Branch–Galveston
Galveston, TX

Maureen Moriarty, MSN, DNP

Graduate Chair for Nursing
Director, DNP Program and RN-BSN Program
Malek School for Health Professions
Arlington, VA

Anthony L. Rostain, MD, MA

Professor of Psychiatry and Pediatrics
University of Pennsylvania Perelman School of Medicine
Medical Director, Penn Behavioral Health Adult ADHD Treatment & Research Program
Director, Neurodevelopmental Psychiatry Program
The Children's Hospital of Philadelphia
Philadelphia, PA

Christine M. Waszynski, DNP, APRN, GNP-BC

Geriatric Nurse Practitioner and Coordinator
Inpatient Geriatric Consult Service
Hartford Hospital
Hartford, CT


Adult/Family Nurse Practitioner
Owner – Wright & Associates Family Healthcare
Concord and Amherst, NH

Physician Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education Accreditation Statement

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through joint providership of Global Education Group and Physicians' Education Resource®, LLC (PER®). Global Education Group is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number: 1561024.

Credit Designation

This activity is approved for 1.25 contact hour(s), which includes 0.0 hour(s) of pharmacology. Activity ID #2691E.

This activity was planned in accordance with AANP CE Standards and Policies.

Physician Assistants Accreditation Statement

The American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME or a recognized state medical society.

Physician Credit Designation

Physician assistants may receive a maximum of 1.25 hours of Category 1 credit for completing this program.

Disclosures of Conflicts of Interest

Lawrence Herman, MPA, PA-C, DFAAPA

  • Consultant: Novo Nordisk
  • Speakers Bureau: Novo Nordisk

Maureen Moriarty, MSN, DNP

  • Consultant: Allergan, Amgen, Novartis
  • Speakers Bureau: Allergan, Amgen, Novartis

Anthony L. Rostain, MD, MA

  • Grant/Research Support: SUNY Upstate
  • Consultant: Shire, Ironshore, Arbor, Major League Baseball, National Football League
  • Royalties: Routledge/Taylor Francis from St. Martin’s Press

Christine M. Waszynski, DNP, APRN, GNP-BC

  • None


  • Consultant: Pfizer, Merck, Arbor, Sanofi
  • Speakers Bureau : Pfizer, Merck, Sanofi

The staff of Physicians' Education Resource®, LLC, (PER®) have no relevant financial relationships with commercial interests to disclose.

Instructions for This Activity and Receiving Credit

  1. You will need to log in to participate in the activity.
  2. Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review audio files/content until you finish the presentation.
  3. At the end of the activity, educational content/audio files will be available for your reference.
  4. In order to receive a CME/CE certificate, you must complete the activity.
  5. Complete the Posttest and pass with a score of 70% or higher, complete the Evaluation, and then click on “Request for Credit.” You may immediately download a CME/CE certificate upon completion of these steps.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME/CE activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME/CE activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER®.